These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11366466)

  • 1. Treatment interruption research: the trial most needed now.
    Scondras D
    AIDS Treat News; 1999 Jun; (No 320):3. PubMed ID: 11366466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-2 study results in confusion.
    TreatmentUpdate; 1999 Jul; 11(5):4-6. PubMed ID: 11366929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
    Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
    AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA explores new antiretroviral trial designs: interview with David Feigal, M.D. Interview by John S. James.
    Feigal D
    AIDS Treat News; 1997 Jun; (No 273):1-5. PubMed ID: 11364399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection.
    Cardiello PG; Hassink E; Ananworanich J; Srasuebkul P; Samor T; Mahanontharit A; Ruxrungtham K; Hirschel B; Lange J; Phanuphak P; Cooper DA
    Clin Infect Dis; 2005 Feb; 40(4):594-600. PubMed ID: 15712083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-20: 5-drug combination trial for heavily treated NNRTI-naive patients now recruiting.
    AIDS Treat News; 1999 Jul; (No 323):2-3. PubMed ID: 11366569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic HIV viraemia during a drug holiday: an argument against treatment interruption?
    Freedman E; Dhaliwal K; Estcourt C; Baily G
    Int J STD AIDS; 2004 Aug; 15(8):564-5. PubMed ID: 15307970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Directions for HIV research.
    Learned J
    Posit Aware; 2000; 11(1):32-5. PubMed ID: 11366348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weekly intermittent treatment: caution.
    James JS
    AIDS Treat News; 2000 Jul; (347):2-3. PubMed ID: 12170982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulsed therapy and structured interruptions of treatment.
    Proj Inf Perspect; 1999 Apr; (27):12-4. PubMed ID: 11366729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment interruption: most patients could not maintain immune control.
    James JS
    AIDS Treat News; 2004; (407-408):6. PubMed ID: 15717383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [How HIV treatment can be simplified. "Once daily" as starter therapy is effective].
    Wepner U
    MMW Fortschr Med; 2009 Apr; 151(18):80-1. PubMed ID: 19769085
    [No Abstract]   [Full Text] [Related]  

  • 13. Virological characterization of patients treated early is able to control HIV-1 replication after multiple cycles of structured therapy interruption.
    Rozera G; Abbate I; D'Offizi G; Corpolongo A; Narciso P; Vlassi C; Martini F; Calcaterra S; Capobianchi MR
    J Med Virol; 2007 Aug; 79(8):1047-54. PubMed ID: 17597482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment interruptions in HIV-infected subjects.
    Bongiovanni M; Casana M; Tincati C; d'Arminio Monforte A
    J Antimicrob Chemother; 2006 Sep; 58(3):502-5. PubMed ID: 16816398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-2 (IL-2, Proleukin).
    Proj Inf Perspect; 1999 Apr; (27):21-2. PubMed ID: 11366737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotype of HIV+ patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system.
    Nemes E; Lugli E; Nasi M; Ferraresi R; Pinti M; Bugarini R; Borghi V; Prati F; Esposito R; Cossarizza A; Mussini C
    AIDS; 2006 Oct; 20(16):2021-32. PubMed ID: 17053348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New study: stopping therapy.
    Vazquez E
    Posit Aware; 1999; 10(4):25. PubMed ID: 11366800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remune trial ended.
    Res Initiat Treat Action; 1999 Jul; 5(3):28. PubMed ID: 11366725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients.
    Ruiz L; Paredes R; Gómez G; Romeu J; Domingo P; Pérez-Alvarez N; Tambussi G; Llibre JM; Martínez-Picado J; Vidal F; Fumaz CR; Clotet B;
    AIDS; 2007 Jan; 21(2):169-78. PubMed ID: 17197807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should we now adopt the HIV-RNA < 50 copy endpoint for clinical trials of antiretroviral-experienced as well as naive patients?
    Hill A; Miralles D; Vangeneugden T; Lefebvre E
    AIDS; 2007 Jul; 21(12):1651-3. PubMed ID: 17630565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.